You just read:

British Artificial Intelligence Firm Announces Exclusive License Agreement with Janssen for Clinical Stage Drug Candidates, Facilitated by Johnson & Johnson Innovation

News provided by

BenevolentAI

08 Nov, 2016, 06:03 ET